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ABSTRACT
This paper describes and illustrates a novel method
of microarray data analysis that couples model-based
clustering and binary classification to form clusters
of ‘response-relevant’ genes; that is, genes that are
informative when discriminating between the different
values of the response. Predictions are subsequently made
using an appropriate statistical summary of each gene
cluster, which we call the ‘meta-covariate’ representation
of the cluster, in a probit regression model. We first
illustrate this method by analysing a leukaemia expression
dataset, before focusing closely on the meta-covariate
analysis of a renal gene expression dataset in a rat model
of salt-sensitive hypertension. We explore the biological
insights provided by our analysis of these data. In particular,
we identify a highly influential cluster of thirteen genes—
including three transcription factors (Arntl, Bhlhe41 and
Npas2)—that is implicated as being protective against
hypertension in response to increased dietary sodium.
Functional and canonical pathway analysis of this cluster
using Ingenuity Pathway Analysis implicated transcriptional
activation and circadian rhythm signaling, respectively.
Although we illustrate our method using only expression
data, the method is applicable to any high-dimensional
datasets. Expression data are available at ArrayExpress
(accession number E-MEXP-2514) and code is available at
http://www.dcs.gla.ac.uk/inference/metacovariateanalysis/.
INTRODUCTION
Microarray experiments allow the simultaneous expression
measurements of tens of thousands of genes in a biological
sample and have been employed extensively to investigate
human disease since the early nineties [e.g., 1]. Despite
almost two decades of research, challenges regarding the
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analysis of these data remain. Typically, the number of
variables (or probes) measured vastly outnumbers the number
of replicate experiments: over thirty thousand probes might
be measured in only three or four samples, making good
predictive performance possible by chance, irrespective of
whether the data contain relevant patterns. In addition, many
variables will exhibit similar patterns across the samples;
we require methods that identify which of these correlations
are the result of genuine functional relationships and/or co-
regulation and which are merely observed by chance. Taken
together, these features make microarray analysis statistically
demanding, prone to variability in model parameter estimates
and ultimately susceptible to inaccurate prediction.
Our meta-covariate method is a novel approach to
analysing microarray data, which overcomes and, in the
case of correlated expression patterns, exploits the statistical
properties of gene expression data, with a view to improving
prediction and identifying biologically relevant structure in the
data [2]. It is, however, applicable to any high dimensional
dataset (including proteomics, sequencing and miRNA
datasets) where informative correlations exist between the
variables. Initially, the D probes are grouped into K clusters,
using gene expression similarity across the N samples and a
standard Gaussian mixture model. An N -dimensional meta-
covariate vector is then generated from each cluster and
predictions are made by weighting these meta-covariates in a
probit regression model. We then take the novel step of using
the prediction performance to update the clustering structure,
the meta-covariates and the regression weights. This iterative
procedure is repeated until convergence (Figure 1).
The approach of reducing microarray data dimensionality
by forming clusters (independent of predictions) and making
subsequent predictions using cluster summaries has been
adopted previously by Hanczar et al. [3] and Park et al. [4]
amongst others. Where our method improves upon existing
methods is that inter-predictor correlations are coupled
with predictor-outcome correlations to inform the clustering
structure, the cluster summaries (meta-covariates) and the
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Figure 1. The meta-covariate method. Expression data are used to form
clusters of probes (clustering is represented by the D×K matrix of
responsibilities γ). N-dimensional meta-covariates (θk) are calculated from
these clusters and used to make predictions in a probit regression model
(with regression coefficients w). The novelty of our method is highlighted in
turquoise: the prediction performance is used to update γ, θk and w, thereby
iteratively improving the cluster structure and the prediction performance.
regression weights (indicated by the turquoise arrow in Figure
1). The advantages of our method are three-fold. Firstly,
the clustering component of the model identifies response-
relevant structure in the data, aiding biological interpretation.
Secondly, the regression coefficients allow the identification of
influential clusters: the greater the weight assigned to a cluster
in the regression model, the more ‘informative’ that cluster
is when discriminating between the outcomes of the response
variable. And finally, using the predictor-response correlations
to fine-tune the clustering structure in the model potentially
improves prediction performance.
In this paper, we will first demonstrate how the meta-
covariate method works using the well known leukaemia
dataset described by Golub et al. [5]. We will then employ
the method to analyse gene expression data in the rat kidney
to investigate the genetics of salt-sensitive hypertension.
MATERIALS AND METHODS
Leukaemia data
In the Golub et al. [5] dataset, bone marrow or peripheral
blood samples were taken from 25 AML and 47 ALL
patients. The training data contain 38 samples, of which 11
are AML and 27 are ALL samples. The test data contain
34 samples, of which 14 are AML and 20 are ALL. RNA
extracted from these samples was tagged and subsequently
hybridized to a high density Affymetrix oligoneuclotide
microarray (Hu6800/HuGeneFL). The expression data were
obtained from the Broad Institute Website and preprocessed
as recommended in Dudoit et al. [6] (see Supplementary
Materials for details), leaving 3571 probes for analysis.
Animal strains
Inbred colonies of SHRSP and WKY have been maintained at
the University of Glasgow since 1991, as previously described
[7]. From weaning, all rats were maintained on normal rat
chow (rat and mouse No.1 maintenance diet, Special Diet
Services) and at 18 weeks of age rats were given a salt
challenge (1% NaCl in drinking water) for three weeks.
The congenic strain SP.WKYGla2a (D2Rat13-D2Rat157)
was generated using a marker-assisted “speed” congenic
strategy [8] where a WKY (donor strain) segment was
introgressed into the SHRSP (recipient strain) genetic
background.
Microarray data analysis Affymetrix Rat 230-2
Affymetrix GeneChip renal expression analysis was used
to identify differentially expressed probe sets (representing
unique gene or expressed sequence tag sequence on the
Affymetrix GeneChip) between male, 21-week old, age-
matched salt-loaded and non-treated SHRSP, SP.WKYGla2a,
and WKY rats. Whole kidneys (harvested between 10am and
12 noon and snap frozen in liquid nitrogen) were homogenized
and total RNA extracted from 3 rats from each strain by using
the maxi RNeasy kit according to the manufacturers protocol
(Qiagen). Biotinylated amplified target cRNA was prepared
and hybridized to the Affymetrix Rat Rat230-2 gene chips
as described by Affymetrix. After hybridization, microarray
chips were washed, stained and scanned. The microarray data
were normalized in R using RMA [9]. To assess the statistical
significance of pairwise intergroup differences, Rank Products
(RP) [10] was used, corrected for multiple testing using a false
discovery rate of 5% [11]. The microarray dataset has been
submitted to ArrayExpress (Accession Number E-MEXP-
2514).
Quantitative Real-Time Polymerase Chain Reaction
Renal total RNA was extracted from 21-week-old salt loaded
and non-treated male rats using RNeasy kits (Qiagen), treated
with DNase-Free RNase (Ambion), and accurately quantified.
qRT-PCR was performed using Taqman (Applied Biosystem,
UK) Actb (β-actin) labeled Vic, as a normalization control and
either Arntl (Rn00577590 m1), Npas2 (Rn01438224 m1),
Nfil3 (Rn01434874 s1) and Bhlhe41 (Rn00591084 m1)
labeled FAM. Arntl, Npas2, Nfil3 and Bhlhe41 were
normalised to Actb, expressed relative to SHRSP (non salt
treated) in each sample using the comparative (∆∆CT)
method.
Description of method
As described in the Introduction, the novelty of this
method lies in the coupling of the clustering and prediction
components (as depicted by the turquoise arrow in Figure
1). These components are coupled by optimising all
the parameters (i.e., the parameters pertaining to both
components) simultaneously, rather than optimising the
clustering parameters before the prediction parameters. Here,
we have chosen a Gaussian mixture model as the clustering
model [12, Section 9.2] and probit regression [12, Section
4.3.5] as the prediction method. We optimise the parameters
of these models using the Expectation-Maximisation (EM)
algorithm [12, Section 9.4], which finds the most likely
parameter estimates in a probabilistic model by updating them
over a number of iterations. Our model updates are derived
by merging the standard EM updates for the clustering and
regression parameters.
Intuitively, the meta-covariate model can be thought of as
follows: (A) all probes on the array are clustered into K
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groups, and each group is then represented by some average
of its members; (B) these clusters averages (which we call
the ‘meta-covariates’) are then used to predict the response by
assigning each meta-covariate a weight in a regression model;
(C) we update the cluster structure (step A) and the regression
weights (step B) depending on how well the meta-covariate
regression model predicts the response. It is also important to
appreciate that this method can be used as an exploratory tool
as well as a prediction algorithm.
The significant parameters in this model are θ, pi, Σ, γ and
w. w is a vector, containing the weights assigned to each
meta-covariate (and therefore each cluster) in the regression
model. Each value in w indicates how much influence each
cluster has in determining the value of the response and
therefore how informative it is when discriminating between
different values of the response (in the hypertension dataset,
the response is salt-loaded or non-salt-loaded, while in the
leukaemia dataset, the response is AML or ALL). The other
four parameters are relevant to the clustering model. θ is a
matrix containing the meta-covariate representations of the
clusters and Σ is a matrix that describes the variance within
each cluster in the model; i.e., θk and Σk=diag(σ2k1 ,...,σ
2
kN
)
are the mean and covariance of the kth cluster. pi is a vector
containing the proportion of probes in the dataset that are
assigned to each cluster, which are the ‘mixing coefficients’.
γ is a matrix containing the ‘responsibilities’ that each cluster
k takes for explaining each probe; each element of γ can be
interpreted as the probability that a particular probe belongs to
a particular cluster (the γ values for any probe will sum to 1).
To generate assignments, a probe is assigned to the cluster to
which it has the highest probability of belonging. Using such
‘soft’ clustering (rather than ‘hard’ clustering, where each
probe is assigned to a cluster with a probability of 1), aids
the interpretation of the model.
Our EM procedure iteratively updates the values of pi, θ,
Σ, γ and w (and others, see Supplementary Materials) until
the model converges. More specifically, given some number
of clusters K, the goal is to maximise the log joint distribution
with respect to the parameters, pi, θ, Σ, γ and w, until
the model converges. Here, the convergence criterion are an
increase in the log joint distribution of ≤0.00001 or some
maximum number of iterations. Note that the value of K must
be set before optimisation, necessitating a model selection step
that identifies which K is best for a given dataset.
Full details of our method are given in the Supplementary
Materials, Sections 1.2-1.3 and MATLAB code is available at
http://www.dcs.gla.ac.uk/inference/metacovariateanalysis/.
Mapping and Ingenuity Pathway Functional Analyses
All probe to gene mappings; gene to pathway mappings and
network analysis tools were taken from Ingenuity Pathway
Analysis software (IPA, http://www.ingenuity.com/) as of
October 2009. Molecular interactions between genes were
mapped to a common pathway using Pathway Explorer
function within Ingenuity Pathway Analysis software.
RESULTS AND DISCUSSION
A well established leukaemia dataset containing expression
data for acute myeloid leukaemia (AML) and acute lymphoid
leukaemia (ALL) was used initially to illustrate our method
[2]. Our method was then applied to a novel dataset of renal
gene expression data with a view to providing insight into salt-
sensitive hypertension. Throughout this section, clusters will
be represented as CDn where n gives the ID of that cluster
in the dataset D (D∈{leuk,salt}) where leuk denotes the
Golub et al. dataset and salt denotes the hypertension dataset.
The leukaemia data analysis
Leukaemia is a broad term to describe cancer of the blood or
bone marrow. Haemopoiesis, the process of blood production,
is organised hierarchically with the haemopoietic stem cell at
the apex. The first major lineage diversion is between myeloid
and lymphoid progenitors. In acute myeloid leukaemia (AML)
there is a block to differentiation with a rapid accumulation
of abnormally proliferating myeloid blasts. This process is
mirrored in acute lymphoid leukaemia (ALL), but in this case,
the blasts are of lymphoid morphology [13, Chapter 12].
In 1999, Golub et al. published work in which previously
unseen samples could be classified according to their gene
expression profiles; using a weighted vote of 50 probes, they
successfully classified all but one of the samples in the test set
of 34 samples (14 AML and 20 ALL samples). This dataset
has been subject to extensive analysis in the past decade
and predictions made from these data are consistently of
good quality, regardless of the approach taken: using a sparse
Bayesian classification model, Bae and Mallick misclassified
two test samples [14]; Lee and Lee [15] used support vector
machines to analyse an extended multinomial version of the
Golub et al. dataset and achieved a misclassification rate of 1;
Tibshirani et al. [16] used the nearest shrunken centroids and
misclassified two samples; and using a hierarchical Bayesian
model, Lee et al. [17] misclassified only one sample.
Although AML and ALL are both forms of leukaemia,
they cause accumulation of different types of cell [5]. As
such, there will be many differences between the two sets
of samples in this dataset that are attributable to cell type,
rather than the molecular pathology of the two diseases.
These cellular differences may be responsible for the ease
with which the AML and ALL samples are discriminated in
the literature. It must also be noted that there are subtypes
of AML and ALL [18]—in the process of haemopoiesis,
myeloid and lymphoid progenitor cells give rise to further
cell lineages, where subtypes of AML and ALL describe
cancers exhibiting variable levels of differentiation towards
mature myeloid and lymphoid cells—and that the Golub et al.
dataset pools all AML and ALL subtypes together. In addition
to the heterogeneity inherent in the disease, the samples in
the dataset vary with respect to the age of the patient and
with respect to sample type (e.g., both bone marrow aspirates
and peripheral blood mononuclear samples are used). As
such, we expect that any biology captured by our model
would represent very ‘general’ characterisations of myeloid
and lymphoid cells.
The meta-covariate analysis of the leukaemia data
The Golub data were pre-filtered as described by Dudoit et al.
[6]. In our representation, AML samples have been encoded
as 1 and ALL samples have been encoded as 0; therefore,
positively weighted clusters are predictive of AML samples
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(these clusters will be described as AML+) and negatively
weighted clusters are predictive of ALL (such clusters will be
described as ALL+). A model selection step identified K=22
as the best model using the criteria of minimum average test
error (the model selection step performed 1000 iterations of
the EM algorithm, where 2<K<50).
The maximum a posteriori (MAP) [12, pp. 30] solution for
this model discriminates perfectly between AML and ALL
samples, in both the training and test set, providing evidence
that our meta-covariate model is able to make good predictions
and suggesting that the clusters formed are response-relevant
and, therefore, potentially biologically relevant.
Cluster morphology The meta-covariate model algorithm was
run to convergence—the criterion being a difference in
the joint posterior of <0.0001 and a maximum of 5000
iterations—on the leukaemia data, partitioning the probes into
22 clusters. These clusters and their associated regression
coefficients (w), dataset proportion (pi) and mean variance
(σ2, the variance in expression of cluster members, averaged
over samples) are described in Table 1. There is a marginal
trend for |wk| to decrease with cluster size (ρ=−0.37,p=
0.09). However, there is a significant correlation between the
mean variance in the cluster and its influence (ρ=0.54,p=
0.01). This is perhaps contrary to expectation. It might be
expected that the most influential clusters would identify
transcriptionally tight clusters of genes corresponding to
specific sub-functionality; however, the opposite is true: the
more influential clusters are more variable.
This can be explained by considering how θk is calculated
(see Equation 4 in the Supplementary Materials). θk is
comprised of both a model mismatch component, which
Table 1. The 22 clusters obtained by meta-covariate analysis of the leukaemia
data (clusters are ordered by abs(w)). w is the regression coefficient of the
cluster, pi is the size of the cluster (as a percentage of the whole dataset), σ2 is
the mean variance of the cluster.
Cluster Probes w pi σ2
10 62 -5.32 1.79×10-2 7.34 ×10-1
12 96 2.55 2.70×10-2 6.69 ×10-1
21 177 2.43 4.93×10-2 3.94 ×10-1
14 214 -2.30 5.95×10-2 2.10 ×10-1
5 142 2.17 3.96×10-2 2.59 ×10-1
19 37 -1.91 1.06×10-2 4.88 ×10-1
22 124 1.73 3.49×10-2 9.13 ×10-1
3 179 -1.71 5.02×10-2 1.18 ×10-1
4 190 -1.65 5.42×10-2 2.37 ×10-1
8 263 1.25 7.33×10-2 1.31 ×10-1
15 143 1.04 3.99×10-2 2.39 ×10-1
1 75 1.00 2.12×10-2 1.92 ×10-1
7 52 -0.85 1.45×10-2 2.68 ×10-1
16 339 -0.79 9.54×10-2 2.99 ×10-1
11 111 0.56 3.09×10-2 6.57 ×10-1
20 162 0.53 4.50×10-2 1.72 ×10-1
13 202 0.50 5.62×10-2 1.42 ×10-1
2 191 -0.30 5.35×10-2 2.61 ×10-1
9 210 -0.27 5.78×10-2 2.16 ×10-1
18 265 -0.17 7.48×10-2 1.45 ×10-1
6 98 0.15 2.71×10-2 2.88 ×10-1
17 239 -0.04 6.69×10-2 1.12 ×10-1
describes how well the current classification model matches
the response data, and a standard clustering component [12,
Section 9.2.2]. As the cluster size decreases, that is, as γk
becomes more sparse (where γk is the vector of clustering
responsibilities for cluster k) , the model mismatch terms
will dominate the calculation of θk as the standard clustering
component, dependent on γk, will diminish. Conversely, as
the cluster becomes larger and γk becomes less sparse,
the standard mixture modelling component will dominate
the calculation. Furthermore, as the cluster becomes more
influential and the value of |wk| increases, the model
mismatch term will dominate further. Therefore, the model
will tend to form smaller, influential, more variable clusters
and larger, less influential and less variable clusters, thereby
automatically inducing sparsity in the model.
Capturing large-scale, biological functionality The model is
capable of capturing large-scale biological functionality that is
of relevance to the response. As expected, the biology captured
by the most influential clusters in this dataset describes
functions characteristic of myeloid and lymphoid cells.
Cleuk10 is the most influential cluster in the model
generated from the leukaemia data (Figure 2(a)). The
expression of the genes in this cluster is associated with
ALL samples. Cleuk10 is enriched for elements in the
“MIF regulation of innate immunity” pathway, due to
the inclusion of MIF and its cell surface receptor CD74
[19] in the cluster (Supplementary Figure 2). MIF is a
lymphokine, a signalling molecule expressed by lymphocytes
(http://www.ncbi.nlm.nih.gov/gene/4282), which has been
shown to play a role in T cell tumourigenesis [20] and
lymphocyte proliferation [21, 22]. CD74 is expressed on
malignant B cells (a form of lymphoid cell), but is expressed
to a much lesser extent on non-malignant cell surfaces [23]
(Supplementary Figure 3).
Cleuk12 is the most influential AML+ cluster (Figure 2(b)).
The most over-represented IPA pathway in this cluster is
the “triggering receptor expression on myeloid cells 1”
(or TREM1) signalling pathway (Supplementary Figure 4).
TREM1 activation has various roles in both the adaptive and
innate immune response, but critically, it is only expressed
in myeloid cells (Supplementary Figure 5). This cluster
is also enriched for “acute myeloid leukaemia signalling”
proteins; in fact, the top five AML+ clusters (Cleuk12 , Cleuk21 ,
Cleuk5 , Cleuk22 and Cleuk8 ) are all enriched for this pathway(Supplementary Figure 6). This IPA canonical pathway
describes the signalling pathways which, when disrupted by
abnormalities (e.g., mutations to genes and/or transcription
factors), can lead to increased proliferation and apoptosis
resistance in AML. These two pathways are myeloid-specific,
describing processes that occur exclusively in myeloid cells.
Clusters can also represent more specific, biological sub-
functionality The predictive ability of each cluster only exists
within the meta-covariate model. Although some clusters
may clearly discriminate between AML and ALL samples,
others may be good at predicting subtypes of either disease.
ALL samples can be further sub-classified as T or B cell
ALL. Cleuk19 is an example of one of these ‘subtype specific’
clusters. It is ALL+, with a regression coefficient of -1.91.
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(a) ALL+ Cleuk
10
(w=−5.32) (b) AML+ Cleuk
12
(w=2.55) (c) ALL+ Cleuk
19
(w=−1.91)
Figure 2. Expression, mean expression (µ) and θk vectors for three clusters generated by the meta-covariate method, when analysing the leukaemia data.
Extended versions with sample IDs are available in Supplementary Figures 14-16.
From the expression plot in Figure 2(c), it is clear that
this cluster is important when classifying specifically T cell
ALL samples: expression in these samples is visibly higher,
while expression in the B cell ALL and AML samples
is similarly low. This cluster is enriched for several T
cell lymphocyte specific canonical pathways, including the
“Calcium-induced T lymphocyte apoptosis”; “iCOS-iCOSL”
and “CD28 Signalling in T Helper Cells”; “cytotoxic T
lymphocyte-mediated apoptosis of target cells” and “T cell
receptor signalling” IPA canonical pathways (Supplementary
Figure 7).
Sub-type specific clusters can arise in our model because
complementary clusters, which are able to predict the other
subtype(s) within a class, can exist. An example of a
complementary cluster to Cleuk19 is Cleuk14 (Supplementary
Figure 8); here, the cluster contains genes that are more highly
expressed in B cell ALL samples than T cell ALL and AML
samples.
Applying our meta-covariate method to novel renal, gene
expression data
In the previous section, we illustrated the use of our meta-
covariate method by applying it to a well-known leukaemia
dataset. We observed that the influential clusters tend to
be smaller and more variable than the less influential
clusters and that the model is able to capture both large-
scale biological characteristics and small-scale, more specific
biological characteristics. In the next section, our method is
applied to a dataset of renal gene expression profiles in a rat
model of salt-sensitive hypertension.
The hypertension data analysis
Essential hypertension (chronically elevated blood pressure) is
a genetically complex disease, currently affecting one quarter
of adults worldwide and projected to affect almost 30% of
adults within 15 years [24]. One half of hypertensive patients
are salt sensitive, exhibiting increased blood pressure with
increased dietary sodium [25]. Elucidating the genetics of
hypertension would have far-reaching implications for global
health. Animal models are useful functional models allowing
the genetic dissection of complex, polygenic disease; the data
described here are derived from a rat model of salt-sensitive
hypertension [26].
The SHRSP, Wistar-Kyoto (WKY) and congenic
SP.WKYGla2a strains of rat are distinct with respect to
phenotype in response to salt, with the SHRSP demonstrating
increased systolic blood pressure and circadian amplitude
in response to salt, the WKY being largely unaffected by
salt, and the SP.WKYGla2a demonstrating an intermediate
increase in both systolic blood pressure and circadian
amplitude in response to salt [27, Supplementary Figure 9].
Microarray experiments were conducted to measure renal
gene expression in male, age-matched, 21 week old salt-
loaded and non-salt-loaded animals. The resulting dataset was
analysed using our meta-covariate method. Genes contained
in influential clusters will be informative when discriminating
between salt-loaded samples and non-salt-loaded samples.
Furthermore, identifying gene expression changes between
SP.WKYGla2a and SHRSP will highlight chromosome 2
dependent processes involved in blood pressure regulation.
The sample size (n=18) is small; as such, we used all
the data to build the model, rather than making predictions
on a test set. However, here we can demonstrate the second
use of our method, by employing it as a valuable supervised
clustering tool to generate response-relevant clusters within
the given dataset, rather than using it primarily to build
a classifier (as demonstrated in the previous section when
analysing the leukaemia data).
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4,562 probes on the array were identified as significant
using the Wilcoxon rank-sum test (p≤0.05). K was set to
20, following 1000 iterations of the method for each value of
K where 2<K<50, and subsequent analysis using Bayesian
Information Criterion (BIC); for K=20, BIC=85731. BIC is
a regularised model selection technique, which identifies the
most likely values of the model parameters, whilst penalising
unnecessary model complexity [12, Section 4.4.1]. Upon
completion, the meta-covariate model successfully partitioned
the dataset with respect to salt.
Cluster morphology The twenty clusters that are formed are
described in Table 2. Here, there is an imbalance of positively
and negatively weighted clusters—12 negative to 8 positive—
unlike in the leukaemia model (Table 1) where there were
equal numbers of positively and negatively weighted clusters.
This model is dominated by heavily, negatively weighted
clusters: the three most influential clusters (Csalt13 , w=
−46.76; Csalt8 , w=−9.59; Csalt5 , w=−7.13) are all
negatively weighted (note also that these three clusters
have similar variance). This suggests the dominant biology
captured by this model is reduced expression in the salt-
loaded animals. That is, the biology that contributes most
significantly to the discrimination between the salt-loaded and
non-salt-loaded samples is that of lower expression in the
salt-loaded samples.
Cluster size is significantly inversely correlated with
regression weight (ρ=−0.46, p=0.04) and significantly
correlated with average variance (ρ=0.67, p<0.01).
Therefore, as observed in the leukaemia dataset, the method
has generated both small, variable (with respect to member
gene expression), influential clusters and large, tight,
non-influential clusters.
Table 2. The 20 clusters obtained by meta-covariate analysis of the salt data
(clusters are ordered by abs(w)). w is the regression coefficient of the cluster,
pi is the size of the cluster (as a percentage of the whole dataset), σ2 is the
mean variance of the cluster.
Cluster Probes w pi σ2
13 13 -46.76 2.71×10-3 2.27×10-1
8 7 -9.59 1.51×10-3 2.26×10-1
5 14 -7.13 3.14×10-3 2.33×10-1
3 70 4.27 1.54×10-2 5.59×10-2
15 301 -3.32 6.61×10-2 2.37×10-2
6 317 -3.08 6.96×10-2 2.31×10-2
14 284 -2.69 6.23×10-2 2.51×10-2
2 408 2.65 8.95×10-2 1.52×10-2
16 329 2.02 7.19×10-2 1.95×10-2
4 454 1.85 9.95×10-2 1.58×10-2
19 28 -1.54 6.18×10-3 1.13×10-1
17 336 -1.44 7.29×10-2 2.13×10-2
10 361 1.35 7.93×10-2 2.05×10-2
1 163 1.00 3.62×10-2 3.07×10-2
7 316 -0.88 6.91×10-2 2.29×10-2
11 231 0.82 5.07×10-2 2.46×10-2
20 90 0.80 1.96×10-2 4.53×10-2
9 310 -0.58 6.85×10-2 2.24×10-2
12 282 -0.28 6.15×10-2 2.38×10-2
18 248 -0.10 5.45×10-2 2.09×10-2
This feature of our model is particularly useful in this
dataset, where all of the 4562 probes are significantly
correlated with the response. The induced sparsity allows
identification of the most relevant features, in a congested
dataset where all features are relevant by traditional, univariate
methods. Furthermore, there is no correlation between the
Wilcoxon p-value and regression coefficient in this dataset
(ρ=−1.47×10−3, p=9.21×10−1), indicating that the most
valuable predictors (as defined by the meta-covariate model)
would not be selected on the basis of p-value alone.
With a view to establishing (a) how sensitive our method
is to variation in the data and (b) how robust these clusters
are, we performed Leave One Out Cross-Validation (LOOCV)
and compared the models generated from the LOOCV folds to
each other and to the model generated from the full dataset
using two metrics—Adjusted Rand Index (ARI) [28] and
Adjusted Mutual Information (AMI) [29]—both of which
measure concordance between clustering structures, while
accounting for chance. The results are very encouraging:
despite the small sample size, clustering concordance is high
(see Supplementary Figures 10-11 and Supplementary Tables
1-2). The mean concordance between the clustering structures
of the LOOCV fold models and the clustering structure of
the model built from the dataset in its entirety (i.e., the
clustering described in Table 2) is 0.96 (σ=0.011) and 0.96
(σ=0.0070) for the ARI and AMI metrics respectively (all
values rounded to 2 s.f.). This convincingly demonstrates that
a similar clustering structure is observed across LOOCV folds
and, therefore, that the method is insensitive to variation in
the input data. This is particularly encouraging given that an
initial motivation for this method was to avoid such sensitivity.
We can now progress with the analysis of these data, with
confidence in the clustering structure.
An influential cluster of thirteen genes Csalt13 is the most
influential cluster: its regression coefficient is five times larger
than the second most influential cluster. Classification using
this cluster and its regression coefficient in isolation results in
only one misclassification (the SHRSP+salt animal, C3996)
using the decision boundary (y=0). Although we should be
cautious of reading too much into cluster performance in
isolation, given that clusters are only relevant as part of the
model as a whole, it is a useful indicator of how informative a
cluster is in the model.
The negative regression coefficient indicates that the genes
in this cluster are, largely, more highly expressed in the non-
salt-loaded samples than the salt-loaded samples, as is evident
in the graph of the mean expression values (µ) in Figure
3. Comparing the mean expression values to the θ values
illustrates the effect of incorporating an outcome-specific
component in the calculation of θk: the difference between
the non-salt-loaded and salt-loaded samples is exaggerated in
the graph of θ13 (θk where k=13) in Figure 3.
Note that the difference between µ and θ in the renal dataset
is greater than in the leukaemia dataset (Figures 2(a)-2(c) and
Supplementary Figure 8). This suggests that there is greater
discriminative power in the unaltered leukaemia data than in
the unaltered hypertension data. This is not surprising, given
the known heterogeneity in the leukaemia samples and the
comparative homogeneity of the inbred rats. It is encouraging
that the model is able to use patterns that exist in the mean
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(a) WKY salt/no-salt RP overlay (b) 2a salt/no-salt RP overlay (c) SHRSP salt/no-salt RP overlay
(d) Arntl qRT-PCR (e) Npas qRT-PCR (f) Nfil3 qRT-PCR (g) Bhlhe41 qRT-PCR
Figure 4. The contents of Csalt
13
overlaid with the salt-loaded comparisons in the (a) WKY, (b) SP.WKYGla2a and (c) SHRSP animals. Green indicates significant
down-regulation and red indicates significant up-regulation in the salt dataset. RP fold change is indicated below each molecule. Direct relationships are indicated
by a solid line. qRT-PCR of the four transcription factors identified in Csalt
13
confirming significant differences in SP.WKYGla2a and WKY salt loaded animals
(filled) compared to age-matched animals not exposed to salt (open) for (d) Arntl, (e) Npas, (f) Nfil3 and (g) Bhlhe41 (*p<0.05, **p<0.001).
Figure 3. Expression, mean expression (µ) and θk vectors for Csalt13 (w=
−46.76), generated by the meta-covariate method when analysing the
hypertension data. Extended version with sample IDs is given in
Supplementary Figure 17.
gene expression data to build the model, but that it is also able
to alter the cluster representation (i.e., alter θ) to find more
complex informative patterns.
Strain-specific expression of Csalt13 genes Figures 4(a)-4(c)
show the results of a Rank Products (RP) analysis [10]
within each strain, between the salt-loaded and non-salt-
loaded datasets (Supplementary Tables 3-5, chromosome
mappings given in Supplementary Table 6). Most of the
genes are significantly differentially expressed between the
salt-loaded and non-salt-loaded datasets in both the WKY
and SP.WKYGla2a (Figures 4(a) and 4(b) respectively).
However, the same genes are not differentially expressed
when comparing the salt-loaded and non-salt-loaded SHRSP
animals (Figure 4(c)) giving rise to the hypothesis that changes
in expression levels of the genes in Csalt13 are protective
against hypertension in response to an increase in dietary
sodium. These results are corroborated by a Rosetta Resolver
analysis (http://www.rosettabio.com/products/resolver; data
not shown) and the differential expression of the four
transcription factors (Arntl, Npas2, Nfil3 and Bhlhe41) have
been confirmed by qRT-PCR (Figures 4(d)-4(g) respectively).
Circadian rhythm genes are implicated Eleven of the thirteen
probes in this cluster were mapped to genes using IPA. A
canonical pathway analysis of these eleven genes shows that
the cluster is enriched for circadian rhythm signalling genes
(Supplementary Figures 12-13). This is relevant as all three
rat strains demonstrate circadian patterns of systolic blood
pressure: these nocturnal animals have a higher blood pressure
during the night than during the day and this difference and
the circadian amplitude is exacerbated on salt-loading in the
SHRSP (Supplementary Figure 9).
Identifying a transcriptional network within Csalt13 Also
shown in Figures 4(a)-4(c) are the relationships between
the genes in Csalt13 , as described in the Ingenuity Pathway
Knowledge Base. Of note are the four transcription factors,
three of which, neuronal PAS domain protein 2 or Npas2
(also known as Bhlhe9); aryl hydrocarbon receptor nuclear
translocator-like or Arntl (also known as Bmal1 and Bhlhe5);
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(a) Network analysis of 2a dataset (b) Network analysis of WKY dataset
Figure 5. (a) and (b) the most
significant networks identified in
the salt-loaded/non-salt-loaded data,
across the SP.WKYGla2a and WKY
strains respectively. Red indicates
up-regulation in the salt-dataset
compared to no-salt treatment, green
indicates down-regulation in the
dataset, as defined by RP [10];
legend shown above.
and basic helix-loop-helix family member e41 Bhlhe41
(also known as Dec2), are known to form a transcriptional
network and, as seen in a previous section, are potentially
protective against hypertension, being differentially expressed
on salt in the SP.WKYGla2a and WKY strains. These three
transcription factors are central components of the circadian
clock (Supplementary Figure 12). Aryl hydrocarbon receptor
nuclear translocator-like (Arntl) forms a heterodimer with
Clock and is required for E-box-dependent transactivation
activating the transcription of the Per genes from the E-box
elements in its promoter region [30, 31]. Protein products of
Per act together with Cry proteins to inhibit Per transcription,
thus closing the autoregulatory feedback loop. It has been
shown that the basic helix-loop-helix transcription factors
(Bhlhe41) can repress Clock/Bmal1-induced transactivation
of the mouse Per1 promoter through direct protein-protein
interactions with Bmal1 and/or competition for E-box
elements. Disruption of the key molecular oscillators (Arntl,
Npas2) and autoregulatory feedback loops (Bhlhe41, Per,
Dbp, Cry), have recently been shown to be involved in
hypertension [32] and salt sensitivity in both mice [33, 34]
and rats [35].
Identifying a significant transcriptional network The IPA
network generation algorithm was used to form networks of
genes known to be functionally related, as defined by the
Ingenuity Pathway Knowledge Base. This algorithm generates
small (at most 35 genes), densely connected networks from
a set of ‘focus genes’; IPA is able to ‘fill in the gaps’
with linker genes to maximise connectivity in the networks.
Constructing networks around the significantly differentially
expressed genes identified by RP [10] in the salt data, we
can identify networks of functionally related genes that are
relevant to salt-loaded animals.
The same three transcriptional regulators that form the
transcriptional network in Csalt13 are present in the most
significant networks generated from the SP.WKYGla2a (p=
1×10−48) and WKY (p=1×10−46) RP gene expression
microarray data: Arntl, Npas2 and Bhlhe41 (Figures 5(a)-
5(b), Supplementary Tables 7-8). To have arrived at a similar
conclusion both by way of IPA network analysis and by
our meta-covariate method is encouraging. Further, our meta-
covariate method identifies a much smaller set of genes,
allowing more concise interpretation of the data.
Further investigation and validation experiments are
underway, with the priority being the elucidation of how these
genes are linked to chromosome 2 and how they are involved
in sodium homeostasis. In addition, a major focus will be to
investigate why the genes in Csalt13 vary similarly with the
response; this may be due to shared transcriptional regulation.
CONCLUSION
In this paper we describe and illustrate a novel method of
microarray analysis using the Golub et al. [5] leukaemia
dataset, before applying the same analysis to a novel
dataset of renal gene expression data in rat models of salt
sensitive hypertension. It was demonstrated that the prediction
performance of our meta-covariate method is competitive in
the Golub et al. dataset. Although we refrain from drawing
any additional conclusions from these data, beyond the
identification of general patterns, we would like to stress that
further analysis of these data could be informative, provided
the caveats with respect to the experimental design are kept in
mind.
Although we were not able to evaluate prediction
performance in an independent test set given the small size
of the hypertension dataset, the model generated from the
training set was able to perfectly discriminate between salt-
loaded and non-salt-loaded samples. It must also be noted,
however, that it is perfectly valid to use the meta-covariate
method as a supervised clustering technique with a view
to identifying response-relevant gene clusters, as well as a
classification model.
Both datasets demonstrated that the model tends to form
small, variable, influential clusters and larger, tighter, less
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influential clusters. This is particularly useful in a congested,
homogeneous dataset, such as the hypertension dataset, where
many, if not all, variables are significantly correlated with
the response. The flexibility of the model was evident in
that discrimination patterns were identified in the mean gene
expression data where possible, but where these data were not
informative, complex patterns were identified by alternative
representations of the clusters.
We are currently developing a fully Bayesian
implementation of this meta-covariate method—which
will provide a range of clustering structures for a dataset
rather than a single clustering scheme—whilst carrying out
further biological validation of our findings.
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